The arginine methyltransferase CARM1 represses p300•ACT•CREMτ activity and is required for spermiogenesis

Jianqiang Bao, Sophie Rousseaux, Jianjun Shen, Kevin Lin, Yue Lu, Mark T. Bedford

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

CARM1 is a protein arginine methyltransferase (PRMT) that has been firmly implicated in transcriptional regulation. However, the molecular mechanisms by which CARM1 orchestrates transcriptional regulation are not fully understood, especially in a tissue-specific context. We found that Carm1 is highly expressed in the mouse testis and localizes to the nucleus in spermatids, suggesting an important role for Carm1 in spermiogenesis. Using a germline-specific conditional Carm1 knockout mouse model, we found that it is essential for the late stages of haploid germ cell development. Loss of Carm1 led to a low sperm count and deformed sperm heads that can be attributed to defective elongation of round spermatids. RNA-seq analysis of Carm1-null spermatids revealed that the deregulated genes fell into similar categories as those impacted by p300-loss, thus providing a link between Carm1 and p300. Importantly, p300 has long been known to be a major Carm1 substrate. We found that CREM , a key testis-specific transcription factor, associates with p300 through its activator, ACT, and that this interaction is negatively regulated by the methylation of p300 by Carm1. Thus, high nuclear Carm1 levels negatively impact the p300•ACT•CREMτ axis during late stages of spermiogenesis.

Original languageEnglish (US)
Pages (from-to)4327-4343
Number of pages17
JournalNucleic acids research
Volume46
Issue number9
DOIs
StatePublished - May 2018

ASJC Scopus subject areas

  • Genetics

Fingerprint

Dive into the research topics of 'The arginine methyltransferase CARM1 represses p300•ACT•CREMτ activity and is required for spermiogenesis'. Together they form a unique fingerprint.

Cite this